Want to join the conversation?
Thousand Oaks, California-based biopharmaceutical company $AMGN reported 4Q15 net income of $1.8Bil, which grew 39% from 4Q14. GAAP EPS of $2.37 improved 41% from $1.68 last year. 4Q15 revenue increased 4% to $5.54Bil, with 3% product sales growth driven by Enbrel, Sensipar, Prolia, Kyprolis and XGEVA. Adjusted EPS grew 21% to $2.61 in 4Q15.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.